These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 2467085

  • 21. Alpha2-adrenoceptor antagonists evoke endothelium-dependent and -independent relaxations in the isolated rat aorta.
    Kim ND, Kang KW, Kang SY, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):148-52. PubMed ID: 10413081
    [Abstract] [Full Text] [Related]

  • 22. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A, Busse R, Bassenge E.
    Eur J Pharmacol; 1988 Dec 13; 158(3):191-8. PubMed ID: 2908105
    [Abstract] [Full Text] [Related]

  • 23. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P, Cocks T.
    Br J Pharmacol; 1992 Oct 13; 107(2):566-72. PubMed ID: 1384915
    [Abstract] [Full Text] [Related]

  • 24. Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
    Salvemini D, Pistelli A, Vane J.
    Br J Pharmacol; 1993 Jan 13; 108(1):162-9. PubMed ID: 8381319
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells.
    Ito M, Yamamoto I, Naruse A, Suzuki Y, Satake N, Shibata S.
    J Cardiovasc Pharmacol; 1997 Feb 13; 29(2):232-9. PubMed ID: 9057073
    [Abstract] [Full Text] [Related]

  • 29. Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations.
    Hart JL, Jing M, Bina S, Freas W, Van Dyke RA, Muldoon SM.
    Anesthesiology; 1993 Aug 13; 79(2):323-31. PubMed ID: 8393633
    [Abstract] [Full Text] [Related]

  • 30. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
    Mülsch A, Lückhoff A, Pohl U, Busse R, Bassenge E.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul 13; 340(1):119-25. PubMed ID: 2552329
    [Abstract] [Full Text] [Related]

  • 31. Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect.
    Gupta S, McArthur C, Grady C, Ruderman NB.
    Am J Physiol; 1994 May 13; 266(5 Pt 2):H2146-51. PubMed ID: 7911280
    [Abstract] [Full Text] [Related]

  • 32. Characterization of purine receptors in mouse thoracic aorta.
    Bény JL.
    J Cardiovasc Pharmacol; 2004 Aug 13; 44(2):171-7. PubMed ID: 15243297
    [Abstract] [Full Text] [Related]

  • 33. Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
    Renowden S, Edwards DH, Griffith TM.
    Br J Pharmacol; 1992 Jun 13; 106(2):348-53. PubMed ID: 1327377
    [Abstract] [Full Text] [Related]

  • 34. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
    Rubanyi GM, Desiderio D, Luisi A, Johns A, Sybertz EJ.
    J Pharmacol Exp Ther; 1989 Jun 13; 249(3):858-63. PubMed ID: 2499677
    [Abstract] [Full Text] [Related]

  • 35. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ.
    Br J Pharmacol; 2003 Aug 13; 139(7):1289-96. PubMed ID: 12890708
    [Abstract] [Full Text] [Related]

  • 36. Effects of ethacrynic acid and cystamine on sodium nitroprusside-induced relaxation, cyclic GMP levels and guanylate cyclase activity in rat aorta.
    Rapoport RM, Murad F.
    Gen Pharmacol; 1988 Aug 13; 19(1):61-5. PubMed ID: 2894333
    [Abstract] [Full Text] [Related]

  • 37. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.
    Moncada S, Rees DD, Schulz R, Palmer RM.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2166-70. PubMed ID: 1848694
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan 15; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.